PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF ALPHA-ADRENOCEPTOR ANTAGONISTS

被引:16
作者
DONNELLY, R
MEREDITH, PA
ELLIOTT, HL
机构
关键词
D O I
10.2165/00003088-198917040-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:264 / 274
页数:11
相关论文
共 57 条
[1]   ANTIHYPERTENSIVE EFFECT OF DOXAZOSIN IN HYPERTENSIVE PATIENTS - COMPARISON WITH ATENOLOL [J].
BAEZ, MA ;
GARG, DC ;
JALLAD, NS ;
WEIDLER, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S63-S67
[2]  
BATEMAN DN, 1979, EUROPEAN J CLIN PHAR, V16, P171
[3]  
BOLLI P, 1981, J CARDIOVASC PHARM, V2, P399
[4]   FACTORS IN THE CHOICE OF ANTIHYPERTENSIVE THERAPY [J].
BRECKENRIDGE, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 :S5-S8
[5]   KETANSERIN IN ESSENTIAL-HYPERTENSION - USE AS MONOTHERAPY AND IN COMBINATION WITH A DIURETIC OR BETA-ADRENOCEPTOR ANTAGONIST [J].
CAMERON, HA ;
WALLER, PC ;
RAMSAY, LE .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (06) :705-711
[6]   INFLUENCE OF ORAL PRAZOSIN THERAPY ON EXERCISE HEMODYNAMICS IN PATIENTS WITH SEVERE CHRONIC HEART-FAILURE [J].
CHATTERJEE, K ;
RUBIN, SA ;
PORTS, TA ;
PARMLEY, WW .
AMERICAN JOURNAL OF MEDICINE, 1981, 71 (01) :140-146
[7]   THE ANTIHYPERTENSIVE EFFECTS OF DOXAZOSIN - A CLINICAL OVERVIEW [J].
COX, DA ;
LEADER, JP ;
MILSON, JA ;
SINGLETON, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S83-S90
[8]   CLINICAL-PHARMACOLOGY OF DOXAZOSIN IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
CUBEDDU, LX ;
FUENMAYOR, N ;
CAPLAN, N ;
FERRY, D .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (04) :439-449
[9]  
DECREE J, 1981, LANCET, V1, P1161
[10]   DEVELOPMENT OF PHARMACODYNAMIC TOLERANCE TO PRAZOSIN IN CONGESTIVE HEART-FAILURE [J].
DESCH, CE ;
MAGORIEN, RD ;
TRIFFON, DW ;
BLANFORD, MF ;
UNVERFERTH, DV ;
LEIER, CV .
AMERICAN JOURNAL OF CARDIOLOGY, 1979, 44 (06) :1178-1182